Pituitary abnormalities in patients with pediatric growth hormone deficiency in a single tertiary center
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: There is controversy as to whether brain magnetic resonance imaging (MRI) should be performed on all children with growth hormone deficiency (GHD) including those judged to have mild GHD. This study was aimed to determine the frequency of pituitary or intracranial abnormalities in pediatric GHD and to identify risk factors that may predict pituitary or intracranial abnormalities.Methods: A total of 95 pediatric GHD patients were included. Their medical records and brain magnetic resonance (MR) images were reviewed retrospectively.Results: Abnormal pathogenic MR images were found in 14 patients (14.7%), including 10 (10.5%) with pituitary hypoplasia and 4 (4.2%) with pituitary stalk interruption syndrome. Serum levels of insulin-like growth factor-I (IGF-I), IGF-I standard deviation score (SDS), insulin-like growth factor binding protein 3 (IGFBP3), and growth hormone (GH) peak level of GH stimulation test were statistically significantly lower in the group with abnormal brain MRI. The frequency of abnormal MRI was statistically significantly higher in the complete GHD group. IGF-1 SDS showed the highest area under the curve which can predict the presence of brain abnormality with a sensitivity of 85% and a specificity of 71.4%, if IGF-1 SDS was less than -1.365. IGF-1, IGFBP3, and GH peak levels also showed good sensitivity of over 80% for predicting brain abnormalities with cutoff values of 70.285 ng/mL, 1,604 ng/mL, and 4.205 ng/mL, respectively.Conclusion: The sensitivity and specificity of each cutoff value of IGF-1, IGF-1 SDS, IGFBP3, and GH peak levels were good and statistically significant in predicting brain MRI abnormalities. However, it was insufficient to predict all brain abnormalities with these variables. Therefore, we would like to recommend performing a brain MRI if a child is diagnosed with GHD.
Abstract
Purpose: There is controversy as to whether brain magnetic resonance imaging (MRI) should be performed on all children with growth hormone deficiency (GHD) including those judged to have mild GHD. This study was aimed to determine the frequency of pituitary or intracranial abnormalities in pediatric GHD and to identify risk factors that may predict pituitary or intracranial abnormalities.Methods: A total of 95 pediatric GHD patients were included. Their medical records and brain magnetic resonance (MR) images were reviewed retrospectively.Results: Abnormal pathogenic MR images were found in 14 patients (14.7%), including 10 (10.5%) with pituitary hypoplasia and 4 (4.2%) with pituitary stalk interruption syndrome. Serum levels of insulin-like growth factor-I (IGF-I), IGF-I standard deviation score (SDS), insulin-like growth factor binding protein 3 (IGFBP3), and growth hormone (GH) peak level of GH stimulation test were statistically significantly lower in the group with abnormal brain MRI. The frequency of abnormal MRI was statistically significantly higher in the complete GHD group. IGF-1 SDS showed the highest area under the curve which can predict the presence of brain abnormality with a sensitivity of 85% and a specificity of 71.4%, if IGF-1 SDS was less than -1.365. IGF-1, IGFBP3, and GH peak levels also showed good sensitivity of over 80% for predicting brain abnormalities with cutoff values of 70.285 ng/mL, 1,604 ng/mL, and 4.205 ng/mL, respectively.Conclusion: The sensitivity and specificity of each cutoff value of IGF-1, IGF-1 SDS, IGFBP3, and GH peak levels were good and statistically significant in predicting brain MRI abnormalities. However, it was insufficient to predict all brain abnormalities with these variables. Therefore, we would like to recommend performing a brain MRI if a child is diagnosed with GHD.
참고문헌 (29)
- Ranke MB, "Towards a consensus on the definition of idiopathic short stature", Horm Res, 45(Suppl 2), pp.64~66 (1996)
- Lindsay R, "Utah Growth Study : growth standards and the prevalence of growth hormone deficiency", J Pediatr, 125, pp.29~35 (1994)
- Bao XL, "Prevalence of growth hormone deficiency of children in Beijing", Chin Med J(Engl), 105, pp.401~405 (1992)
- Vimpani GV, "Prevalence of severe growth hormone deficiency", Br Med J, 2, pp.427~430 (1977)
- Parkin JM, "Incidence of growth hormone deficiency", Arch Dis Child, 49, pp.904~905 (1974)
- Winer LM, "Basal plasma growth hormone levels in man : new evidence for rhythmicity of growth hormone secretion", J Clin Endocrinol Metab, 70, pp.1678~1686 (1990)
- Carel JC, "Growth hormone testing for the diagnosis of growth hormone def iciency in chi ldhood : a population register-based study", J Clin Endocrinol Metab, 82, pp.2117~2121 (1997)
- Growth Hormone Research Society, "Consensus guidelines for the diagnosis and treatment of growth hormone(GH)deficiency in childhood and adolescence : summary statement of the GH Research Society. GH Research Society", J Clin Endocrinol Metab, 85, pp.3990~3993 (2000)
- Stanley T, "Diagnosis of growth hormone deficiency in childhood", Curr Opin Endocrinol Diabetes Obes, 19, pp.47~52 (2012)
- Maghnie M, "Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism : who, how and when to investigate", J Endocrinol Invest, 27, pp.496~509 (2004)
- Xu C, "MRI features of growth hormone deficiency in children with short stature caused by pituitary lesions", Exp Ther Med, 13, pp.3474~3478 (2017)
- Alba P, "The severity of growth hormone deficiency does not predict the presence or absence of brain magnetic resonance imaging abnormalities-a retrospective review", Eur Endocrinol, 16, pp.60~64 (2020)
- Hwang J, "Prevalence of brain MRI findings in children with nonacquired growth hormone deficiency : a systematic review and meta-analysis", Neuroradiology, 63, pp.1121~1133 (2021)
- Mamilly L, "The necessity of magnetic resonance imaging in the evaluation of pediatric growth hormone deficiency : lessons from a large academic center", Growth Horm IGF Res, 60-61, pp.101427~ (2021)
- AlJurayyan RNA, "Pituitary imaging in 129 children with growth hormone deficiency : A spectrum of findings", Sudan J Paediatr, 17, pp.30~35 (2017)
- Schmitt J, "Brain MRIs may be of low value in most children diagnosed with isolated growth hormone deficiency", J Pediatr Endocrinol Metab, 34, pp.333~340 (2021)
- Sari S, "Measures of pituitary gland and stalk : from neonate to adolescence", J Pediatr Endocrinol Metab, 27, pp.1071~1076 (2014)
- Kim JH, "The 2017 Korean National Growth Charts for children and adolescents : development, improvement, and prospects", Korean J Pediatr, 61, pp.135~149 (2018)
- Hyun SE, "Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents", Clin Biochem, 45, pp.16~21 (2012)
- Ibba A, "IGF1 for the diagnosis of growth hormone deficiency in children and adolescents : a reappraisal", Endocr Connect, 9, pp.1095~1102 (2020)
- Müller EE, "Neuroendocrine control of growth hormone secretion", Physiol Rev, 79, pp.511~607 (1999)
- Shen Y, "Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency : a systematic review with meta-analysis", Eur J Pediatr, 174, pp.419~427 (2015)
- Salmon WD Jr, "A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro", J Lab Clin Med, 49, pp.825~836 (1957)
- Rinderknecht E, "The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin", J Biol Chem, 253, pp.2769~2776 (1978)
- Laron Z, "Somatomedin-1(recombinant insulin-like growth factor-1) : clinical pharmacology and potential treatment of endocrine and metabolic disorders", BioDrugs, 11, pp.55~70 (1999)
- Sims NA, "Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5", J Clin Invest, 106, pp.1095~1103 (2000)
- Cohen P, "Consensus statement on the diagnosis and treatment of children with idiopathic short stature : a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop", J Clin Endocrinol Metab, 93, pp.4210~4217 (2008)
- Kim JH, "Diagnosis and treatment of growth hormone deficiency : a position statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology", Endocrinol Metab(Seoul), 35, pp.272~287 (2020)
- Clemmons DR, "Value of insulin-like growth factor system markers in the assessment of growth hormone status", Endocrinol Metab Clin North Am, 36, pp.109~129 (2007)